Inflammatory bowel disease (IBD) is a group of disorders causing inflammation in the digestive tract. Recent data suggest that dysbiosis may play a pivotal role in the IBD pathogenesis. As microbiome-based therapeutics that modulate the gut ecology have been proposed as a novel strategy for preventing IBD, the aim of presenting study was to evaluate the dextran sulphate sodium (DSS) rat model mainly in terms of microbial shifts to confirm its suitability for dysbiosis study in IBD. Acute colitis was induced using 5% DSS solution for seven days and rats were euthanized five days after DSS removal. The faecal/caecal microbiota was analyzed by next generation sequencing. Disease activity index (DAI) score was evaluated daily. Blood and colon tissue immunophenotyping was assessed by flow cytometry and histological, haematological, and biochemical parameters were also evaluated. The colitis induction was reflected in a significantly higher DAI score and changes in all parameters measured. This study demonstrated significant shifts in the colitis-related microbial species after colitis induction. The characteristic inflammation-associated microbiota could be detected even after a five day-recovery period. Moreover, the DSS-model might contribute to an understanding of the effect of different treatments on extraintestinal organ impairments. The observation that certain bacterial species in the gut microbiota are associated with colitis raises the question of whether these organisms are contributors to, or a consequence of the disease. Despite some limitations, we confirmed the suitability of DSS-induced colitis model to monitor microbial changes during acute colitis, in order to test attractive new microbiome-based therapies.

Department of Forensic Medicine Faculty of Medicine Pavol Jozef Safarik University in Kosice 040 11 Kosice Slovakia

Department of Microbiology and Immunology University of Veterinary Medicine and Pharmacy in Kosice 041 81 Kosice Slovakia

Faculty of Science Institute of Biology and Ecology Pavol Jozef Safarik University in Kosice 041 54 Kosice Slovakia

Institute of Animal Physiology and Genetics of the Czech Academy of Sciences 277 21 Libechov Czech Republic

Zobrazit více v PubMed

GBD 2017 Inflammatory Bowel Disease Collaborators The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: A systematic analysis of the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 2020;5:17–30. doi: 10.1016/S2468-1253(19)30333-4. PubMed DOI PMC

Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606. doi: 10.1038/35079114. PubMed DOI

Harbord M., Annese V., Vavricka S.R., Allez M., Barreiro-de Acosta M., Boberg K.M., Burisch J., De Vos M., De Vries A.M., Dick A.D., et al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J. Crohns Colitis. 2016;10:239–254. doi: 10.1093/ecco-jcc/jjv213. PubMed DOI PMC

Elson C.O., Sartor R.B., Tennyson G.S., Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344–1367. doi: 10.1016/0016-5085(95)90599-5. PubMed DOI

Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702. doi: 10.1016/0016-5085(90)90290-H. PubMed DOI

Melgar S., Karlsson A., Michaëlsson E. Acute colitis induced by dextran sulphate, sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: Correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2005;288:G1328–G1338. doi: 10.1152/ajpgi.00467.2004. PubMed DOI

Mähler M., Bristol I.J., Leiter E.H., Workman A.E., Birkenmeier E.H., Elson C.O., Sundberg J.P. Differential susceptibility of inbred mouse strains to dextran sulphate sodium-induced colitis. Am. J. Physiol. 1998;274:G544–G551. doi: 10.1152/ajpgi.1998.274.3.G544. PubMed DOI

Gaudio E., Taddei G., Vetuschi A., Sferra R., Frieri G., Ricciardi G., Caprilli R. Dextran sulphate sodium (DSS) colitis in rats: Clinical, structural, and ultrastructural aspects. Dig. Dis. Sci. 1999;44:1458–1475. doi: 10.1023/A:1026620322859. PubMed DOI

Kiesler P., Fuss I.J., Strober W. Experimental Models of Inflammatory Bowel Diseases. Cell. Mol. Gastroenterol. Hepatol. 2015;1:154–170. doi: 10.1016/j.jcmgh.2015.01.006. PubMed DOI PMC

Axelsson L.G., Landström E., Goldschmidt T.J., Grönberg A., Bylund-Fellenius A.C. Dextran sulphate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects on CD4 (+) -cell depleted, ethnic and NK-cell depleted SCID mice. Inflamm. Res. 1996;45:181–191. doi: 10.1007/BF02285159. PubMed DOI

Martin J.C., Bériou G., Josien R. Dextran Sulphate Sodium (DSS)-Induced Acute Colitis in the Rat. Methods Mol. Biol. 2016;1371:197–203. doi: 10.1007/978-1-4939-3139-2_12. PubMed DOI

Breider M.A., Eppinger M., Gough A. Intercellular adhesion molecule-1 expression in dextran sodium sulphate-induced colitis in rats. Vet. Pathol. 1997;34:598–604. doi: 10.1177/030098589703400608. PubMed DOI

Yoshida Y., Iwai A., Itoh K., Tanaka M., Kato S., Hokari R., Miyahara T., Koyama H., Miura S., Kobayashi M. Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis. Aliment. Pharmacol. Ther. 2000;14:26–32. doi: 10.1046/j.1365-2036.2000.014s1026.x. PubMed DOI

Osman N., Adawi D., Ahrne S., Jeppsson B., Molin G. Modulation of the effect of dextran sulphate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Dig. Dis. Sci. 2004;49:320–327. doi: 10.1023/B:DDAS.0000017459.59088.43. PubMed DOI

Mizuta Y., Isomoto H., Takahashi T. Impaired nitrergic innervation in rat colitis induced by dextran sulphate sodium. Gastroenterology. 2000;118:714–723. doi: 10.1016/S0016-5085(00)70141-7. PubMed DOI

Wang F., Zhao H.Y., Zhang S.T., Gong Y.Z., Zhang H.F., Zhang C. Effect of enteral nutrition on dextran sulphate sodium-induced colitis in rats. J. Dig. Dis. 2011;12:453–458. doi: 10.1111/j.1751-2980.2011.00518.x. PubMed DOI

Johansson M.E., Gustafsson J.K., Holmén-Larsson J., Jabbar K.S., Xia L., Xu H., Ghishan F.K., Carvalho F.A., Gewirtz A.T., Sjövall H., et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63:281–291. doi: 10.1136/gutjnl-2012-303207. PubMed DOI PMC

Morgan M.E., Zheng B., Koelink P.J., van de Kant H.J., Haazen L.C., van Roest M., Garssen J., Folkerts G., Kraneveld A.D. New perspective on dextran sodium sulphate colitis: Antigen-specific T cell development during intestinal inflammation. PLoS ONE. 2013;8:e69936. doi: 10.1371/journal.pone.0069936. PubMed DOI PMC

Nishida A., Inoue R., Inatomi O., Bamba S., Naito Y., And oh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin. J. Gastroenterol. 2018;11:1–10. doi: 10.1007/s12328-017-0813-5. PubMed DOI

Andrews C.N., Griffiths T.A., Kaufman J., Vergnolle N., Surette M.G., Rioux K.P. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 2011;34:374–383. doi: 10.1111/j.1365-2036.2011.04732.x. PubMed DOI

Wills E.S., Jonkers D.M., Savelkoul P.H., Masclee A.A., Pierik M.J., Penders J. Fecal microbial composition of ulcerative colitis and Crohn’s disease patients in remission and subsequent exacerbation. PLoS ONE. 2014;9:e90981. doi: 10.1371/journal.pone.0090981. PubMed DOI PMC

Adamkova P., Hradicka P., Gancarcikova S., Kassayova M., Ambro L., Bertkova I., Maronek M., Farkasova Iannaccone S., Demeckova V. Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis. Pathogens. 2021;10:152. doi: 10.3390/pathogens10020152. PubMed DOI PMC

Stucchi A.F., Shofer S., Leeman S., Materne O., Beer E., McClung J., Shebani K., Moore F., O’Brien M., Becker J.M. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulphate-induced colitis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2000;279:G1298–G1306. doi: 10.1152/ajpgi.2000.279.6.G1298. PubMed DOI

Friedman D.J., Künzli B.M., A-Rahim Y.I., Sevigny J., Berberat P.O., Enjyoji K., Csizmadia E., Friess H., Robson S.C. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Natl. Acad. Sci. USA. 2009;106:16788–16793. doi: 10.1073/pnas.0902869106. PubMed DOI PMC

Katakura K., Lee J., Rachmilewitz D., Li G., Eckmann L., Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Investig. 2005;115:695–702. doi: 10.1172/JCI22996. PubMed DOI PMC

Kupcova Skalnikova H., Vodickova Kepkova K., Vodicka P. Luminex xMAP Assays to Quantify Cytokines in Cancer Patient Serum. Methods Mol. Biol. 2020;2108:65–88. doi: 10.1007/978-1-0716-0247-8_6. PubMed DOI

Bayne L.J., Vonderheide R.H. Multicolor flow cytometric analysis of immune cell subsets in tumor-bearing mice. Cold Spring Harb. Protoc. 2013;2013:955–960. doi: 10.1101/pdb.prot077198. PubMed DOI

Sproston N.R., Ashworth J.J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front. Immunol. 2018;9:754. doi: 10.3389/fimmu.2018.00754. PubMed DOI PMC

Low D., Nguyen D.D., Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Des. Dev. Ther. 2013;7:1341–1357. doi: 10.2147/DDDT.S40107. PubMed DOI PMC

Munyaka P.M., Rabbi M.F., Khafipour E., Ghia J.E. Acute dextran sulphate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice. J. Basic Microbiol. 2016;56:986–998. doi: 10.1002/jobm.201500726. PubMed DOI

Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulphate, sodium experimental murine colitis. Lab. Investig. 1993;69:238–249. PubMed

Kim J.J., Shajib M.S., Manocha M.M., Khan W.I. Investigating intestinal inflammation in DSS-induced model of IBD. J. Vis. Exp. 2012;60:e3678. doi: 10.3791/3678. PubMed DOI PMC

Wéra O., Lancellotti P., Oury C. The Dual Role of Neutrophils in Inflammatory Bowel Diseases. J. Clin. Med. 2016;5:118. doi: 10.3390/jcm5120118. PubMed DOI PMC

Daniluk J., Daniluk U., Reszec J., Rusak M., Dabrowska M., Dabrowski A. The protective effect of cigarette smoke on the course of dextran sulphate sodium-induced colitis are accompanied by lymphocyte subpopulation changes in the blood and colon. Int. J. Colorectal Dis. 2017;32:1551–1559. doi: 10.1007/s00384-017-2882-9. PubMed DOI PMC

Liu D.Y., Zhao H.M., Zhao N., Lu C., Lu A.P. Effect of Bawei Xilei powder on CD3, CD4, CD8 T-lymphocytes of rats with ulcerative colitis. Zhongguo Zhong Yao Za Zhi. 2008;33:1301–1304. PubMed

Neil G.A., Summers R.W., Cheyne B.A., Carpenter C., Huang W.L., Waldschmidt T.J. Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry. Dig. Dis. Sci. 1994;39:1900–1908. doi: 10.1007/BF02088123. PubMed DOI

Ray K. Deciphering the role of CD8 + T cells in IBD: From single-cell analysis of biomarkers. Nat. Rev. Gastroenterol. Hepatol. 2020;17:595. doi: 10.1038/s41575-020-00362-9. PubMed DOI

Nancey S., Holvöet S., Graber I., Joubert G., Philippe D., Martin S., Nicolas J.F., Desreumaux P., Flourié B., Kaiserlian D. CD8+ cytotoxic T cells induce relapsing colitis in normal mice. Gastroenterology. 2006;131:485–496. doi: 10.1053/j.gastro.2006.05.018. PubMed DOI

Nikolaus S., Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670–1689. doi: 10.1053/j.gastro.2007.09.001. PubMed DOI

Thayer W.R., Charland C., Field C.E. The subpopulations of circulating white blood cells in inflammatory bowel disease. Gastroenterology. 1976;71:379–384. doi: 10.1016/S0016-5085(76)80439-8. PubMed DOI

Zhou G.X., Liu Z.J. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease. J. Dig. Dis. 2017;18:495–503. doi: 10.1111/1751-2980.12540. PubMed DOI

Fournier B.M., Parkos C.A. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 2012;5:354–366. doi: 10.1038/mi.2012.24. PubMed DOI

Tang C., Kakuta S., Shimizu K., Kadoki M., Kamiya T., Shimazu T., Kubo S., Saijo S., Ishigame H., Nakae S., et al. Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing T. Nat. Immunol. 2018;19:755–765. doi: 10.1038/s41590-018-0134-y. PubMed DOI

Uhlig H.H., Powrie F. Dendritic cells and the intestinal bacterial flora: A role for localized mucosal immune responses. J. Clin. Investig. 2003;112:648–651. doi: 10.1172/JCI19545. PubMed DOI PMC

Neurath M.F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 2014;14:329–342. doi: 10.1038/nri3661. PubMed DOI

Shea-Donohue T., Thomas K., Cody M.J., Zhao A., Detolla L.J., Kopydlowski K.M., Fukata M., Lira S.A., Vogel S.N. Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulphate (DSS) -induced colitis. Innate Immun. 2008;14:117–124. doi: 10.1177/1753425908088724. PubMed DOI PMC

Laan M., Cui Z.H., Hoshino H., Lötvall J., Sjöstrand M., Gruenert D.C., Skoogh B.E., Lindén A. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 1999;162:2347–2352. PubMed

Ferretti S., Bonneau O., Dubois G.R., Jones C.E., Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 2003;170:2106–2112. doi: 10.4049/jimmunol.170.4.2106. PubMed DOI

Soehnlein O., Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 2010;10:427–439. doi: 10.1038/nri2779. PubMed DOI

Cherfane C.E., Gessel L., Cirillo D., Zimmerman M.B., Polyak S. Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity. Inflamm. Bowel. Dis. 2015;21:1769–1775. doi: 10.1097/MIB.0000000000000427. PubMed DOI PMC

Banks C., Bateman A., Payne R., Johnson P., Sheron N. Chemokine expression in IBD. The mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn’s disease. J. Pathol. 2003;199:28–35. doi: 10.1002/path.1245. PubMed DOI

McCormack G., Moriarty D., O’Donoghue D.P., McCormick P.A., Sheahan K., Baird A.W. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm. Res. 2001;50:491–495. doi: 10.1007/PL00000223. PubMed DOI

Puleston J., Cooper M., Murch S., Bid K., Makh S., Ashwood P., Bingham A.H., Green H., Moss P., Dhillon A., et al. A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment. Pharmacol. Ther. 2005;21:109–120. doi: 10.1111/j.1365-2036.2004.02262.x. PubMed DOI

Sun F.F., Lai P.S., Yue G., Yin K., Nagele R.G., Tong D.M., Krzesicki R.F., Chin J.E., Wong P.Y. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation. 2001;25:33–45. doi: 10.1023/A:1007023611478. PubMed DOI

Luther S.A., Cyster J.G. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2001;2:102–107. doi: 10.1038/84205. PubMed DOI

Ka M.B., Daumas A., Textoris J., Mege J.L. Phenotypic diversity and emerging new tools to study macrophage activation in bacterial infectious diseases. Front Immunol. 2014;5:500. doi: 10.3389/fimmu.2014.00500. PubMed DOI PMC

Ahrens R., Waddell A., Seidu L., Blanchard C., Carey R., Forbes E., Lampinen M., Wilson T., Cohen E., Stringer K., et al. Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J. Immunol. 2008;181:7390–7399. doi: 10.4049/jimmunol.181.10.7390. PubMed DOI PMC

Kamada N., Hisamatsu T., Okamoto S., Chinen H., Kobayashi T., Sato T., Sakuraba A., Kitazume M.T., Sugita A., Koganei K., et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J. Clin. Investig. 2008;118:2269–2280. doi: 10.1172/JCI34610. PubMed DOI PMC

Lissner D., Schumann M., Batra A., Kredel L.I., Kühl A.A., Erben U., May C., Schulzke J.D., Siegmund B. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD. Inflamm. Bowel Dis. 2015;21:1297–1305. doi: 10.1097/MIB.0000000000000384. PubMed DOI PMC

Barman S., Kayama H., Okuzaki D., Ogino T., Osawa H., Matsuno H., Mizushima T., Mori M., Nishimura J., Takeda K. Identification of a human intestinal myeloid cell subset that regulates gut homeostasis. Int. Immunol. 2016;28:533–545. doi: 10.1093/intimm/dxw034. PubMed DOI

Friedrich M., Pohin M., Powrie F. Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease. Immunity. 2019;50:992–1006. doi: 10.1016/j.immuni.2019.03.017. PubMed DOI

Ajuebor M.N., Hogaboam C.M., Kunkel S.L., Proudfoot A.E., Wallace J.L. The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J. Immunol. 2001;166:552–558. doi: 10.4049/jimmunol.166.1.552. PubMed DOI

Ansari N., Abdulla J., Zayyani N., Brahmi U., Taha S., Satir A.A. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: An aid in the differential diagnosis? J. Clin. Pathol. 2006;59:1066–1072. doi: 10.1136/jcp.2005.034983. PubMed DOI PMC

Schrödl W., Büchler R., Wendler S., Reinhold P., Muckova P., Reindl J., Rhode H. Acute phase proteins as promising biomarkers: Perspectives and limitations of human and veterinary medicine. Proteom. Clin. Appl. 2016;10:1077–1092. doi: 10.1002/prca.201600028. PubMed DOI

Diaz Padilla N., Bleeker W.K., Lubbers Y., Rigter G.M., Van Mierlo G.J., Daha M.R., Hack C.E. Rat C-reactive protein activates the autologous complement system. Immunology. 2003;109:564–571. doi: 10.1046/j.1365-2567.2003.01681.x. PubMed DOI PMC

Żyła E., Dziendzikowska K., Kamola D., Wilczak J., Sapierzyński R., Harasym J., Gromadzka-Ostrowska J. Anti-Inflammatory Activity of Oat Beta-Glucans in a Crohn’s Disease Model: Time- and Molar Mass-Dependent Effects. Int. J. Mol. Sci. 2021;22:4485. doi: 10.3390/ijms22094485. PubMed DOI PMC

Kirdak T., Uysal E., Sezgin E., Cecen G.S., Cavun S. Inflammatory response markers in rats undergoing abdominal surgical procedures. Ann. Gastroenterol. 2020;33:528–535. doi: 10.20524/aog.2020.0511. PubMed DOI PMC

Costa C.A., Tanimoto A., Quaglio A.E., Almeida L.D., Severi J.A., Di Stasi L.C. Anti-inflammatory effects of Brazilian ginseng (Pfaffia paniculata) on TNBS-induced intestinal inflammation: Experimental evidence. Int. Immunopharmacol. 2015;28:459–469. doi: 10.1016/j.intimp.2015.07.002. PubMed DOI

Mitaka C. Clinical laboratory differentiation of infected versus non-infectious systemic inflammatory response syndrome. Clin. Chim. Acta. 2005;351:17–29. doi: 10.1016/j.cccn.2004.08.018. PubMed DOI

Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363–369. doi: 10.1161/01.CIR.0000053730.47739.3C. PubMed DOI

Mürüvvet A., Pınar A.U. Acute Phase Protein Levels in Rats with Experimentally Induced Infectious and Noninfectious Inflammation. J. Dairy Vet. Sci. 2017;4:555642. doi: 10.19080/JDVS.2017.04.555642. DOI

Vavricka S.R., Schoepfer A., Scharl M., Lakatos P.L., Navarini A., Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2015;21:1982–1992. doi: 10.1097/MIB.0000000000000392. PubMed DOI PMC

Kim S.H., Lee W., Kwon D., Lee S., Son S.W., Seo M.S., Kim K.S., Lee Y.H., Kim S., Jung Y.S. Metabolomic Analysis of the Liver of a Dextran Sodium Sulphate-Induced Acute Colitis Mouse Model: Implications of the Gut-Liver Connection. Cells. 2020;9:341. doi: 10.3390/cells9020341. PubMed DOI PMC

Mehta R.L., Kellum J.A., Shah S.V., Molitoris B.A., Ronco C., Warnock D.G., Levin A., Network A.K.I. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit. Care. 2007;11:R31. doi: 10.1186/cc5713. PubMed DOI PMC

Silvestri N.J., Wolfe G.I. Asymptomatic/pause-symptomatic creatine kinase elevations (hyperckemia) Muscle Nerve. 2013;47:805–815. doi: 10.1002/mus.23755. PubMed DOI

Herrlinger K.R., Noftz M.K., Fellermann K., Schmidt K., Steinhoff J., Stange E.F. Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use. Aliment. Pharmacol. Ther. 2001;15:363–369. doi: 10.1046/j.1365-2036.2001.00940.x. PubMed DOI

Ranganathan P., Jayakumar C., Santhakumar M., Ramesh G. Netrin-1 regulates colon-kidney crosstalk through suppression of IL-6 function in a mouse model of DSS-colitis. Am. J. Physiol. Ren. Physiol. 2013;304:F1187–F1197. doi: 10.1152/ajprenal.00702.2012. PubMed DOI PMC

Mahmoodpoor F., Rahbar Saadat Y., Barzegari A., Ardalan M., Zununi Vahed S. The impact of gut microbiota on kidney function and pathogenesis. Biomed. Pharmacother. 2017;93:412–419. doi: 10.1016/j.biopha.2017.06.066. PubMed DOI

Collins C.M., D’Orazio S.E. Bacterial ureas: Structure, regulation of expression and role in pathogenesis. Mol. Microbiol. 1993;9:907–913. doi: 10.1111/j.1365-2958.1993.tb01220.x. PubMed DOI

Suzuki K., Benno Y., Mitsuoka T., Takebe S., Kobashi K., Hase J. Areas-producing species of intestinal anaerobes and their activities. Appl. Environ. Microbiol. 1979;37:379–382. doi: 10.1128/aem.37.3.379-382.1979. PubMed DOI PMC

Wozny M.A., Bryant M.P., Holdeman L.V., Moore W.E. Urease assay and ureas-producing species of anaerobes in the bovine rumen and human feces. Appl. Environ. Microbiol. 1977;33:1097–1104. doi: 10.1128/aem.33.5.1097-1104.1977. PubMed DOI PMC

Kim S.M., Song I.H. The clinical impact of gut microbiota in chronic kidney disease. Korean J. Intern. Med. 2020;35:1305–1316. doi: 10.3904/kjim.2020.411. PubMed DOI PMC

Heikius B., Niemelä S., Lehtola J., Karttunen T.J. Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease. Am. J. Gastroenterol. 1999;94:1062–1069. doi: 10.1111/j.1572-0241.1999.01015.x. PubMed DOI

Ramos L.R., Sachar D.B., DiMaio C.J., Colombel J.F., Torres J. Inflammatory Bowel Disease and Pancreatitis: A Review. J. Crohns Colitis. 2016;10:95–104. doi: 10.1093/ecco-jcc/jjv153. PubMed DOI

Fousekis F.S., Theopistos V.I., Katsanos K.H., Christodoulou D.K. Pancreatic Involvement in Inflammatory Bowel Disease: A Review. J. Clin. Med. Res. 2018;10:743–751. doi: 10.14740/jocmr3561w. PubMed DOI PMC

Bokemeyer B. Asymptomatic elevation of serum lipase and amylase in conjunction with Crohn’s disease and ulcerative colitis. Z. Gastroenterol. 2002;40:5–10. doi: 10.1055/s-2002-19636. PubMed DOI

Barthet M., Lesavre N., Desplats S., Panuel M., Gasmi M., Bernard J.P., Dagorn J.C., Grimaud J.C. Frequency and characteristics of pancreatitis in patients with inflammatory bowel disease. Pancreatology. 2006;6:464–471. doi: 10.1159/000094564. PubMed DOI

Martinelli M., Strisciuglio C., Illiceto M.T., Cardile S., Guariso G., Vignola S., Aloi M., D’Altilia M.R., Alvisi P., Salvatore S., et al. Natural history of pancreatic involvement in paediatric inflammatory bowel disease. Dig. Liver Dis. 2015;47:384–389. doi: 10.1016/j.dld.2015.01.155. PubMed DOI

Ray P., Van Arsdall M.R. Elevated Lipase during Initial Presentation of Ulcerative Colitis in a Pediatric Patient: Do We Check for It. Case Rep. Gastroenterol. 2016;10:568–573. doi: 10.1159/000450699. PubMed DOI PMC

Bilski J., Mazur-Bialy A., Wojcik D., Zahradnik-Bilska J., Brzozowski B., Magierowski M., Mach T., Magierowska K., Brzozowski T. The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract. Mediat. Inflamm. 2017;2017:9074601. doi: 10.1155/2017/9074601. PubMed DOI PMC

Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–434. doi: 10.1038/nature06005. PubMed DOI

Malo M.S., Alam S.N., Mostafa G., Zeller S.J., Johnson P.V., Mohammad N., Chen K.T., Moss A.K., Ramasamy S., Faruqui A., et al. Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut. 2010;59:1476–1484. doi: 10.1136/gut.2010.211706. PubMed DOI

Molnár K., Vannay A., Szebeni B., Bánki N.F., Sziksz E., Cseh A., Győrffy H., Lakatos P.L., Papp M., Arató A., et al. Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease. World J. Gastroenterol. 2012;18:3254–3259. doi: 10.3748/wjg.v18.i25.3254. PubMed DOI PMC

Niepel D., Klag T., Malek N.P., Wehkamp J. Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease. Therap. Adv. Gastroenterol. 2018;11:1756284818769074. doi: 10.1177/1756284818769074. PubMed DOI PMC

González Alayón C., Pedrajas Crespo C., Marín Pedrosa S., Benítez J.M., Iglesias Flores E., Salgueiro Rodríguez I., Medina Medina R., García-Sánchez V. Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life. Gastroenterol. Hepatol. 2018;41:22–29. doi: 10.1016/j.gastrohep.2017.07.011. PubMed DOI

Seyoum Y., Baye K., Humblot C. Iron homeostasis in host and gut bacteri—A complex interrelationship. Gut Microbes. 2021;13:1–19. doi: 10.1080/19490976.2021.1874855. PubMed DOI PMC

Dostal A., Fehlbaum S., Chassard C., Zimmermann M.B., Lacroix C. Low iron availability in continuous in vitro colonic fermentations induces strong dispose of the child gut microbial consortium and a decrease in main metabolites. FEMS Microbiol. Ecol. 2013;83:161–175. doi: 10.1111/j.1574-6941.2012.01461.x. PubMed DOI PMC

Ni J., Wu G.D., Albenberg L., Tomov V.T. Gut microbiota and IBD: Causation or correlation? Nat. Rev. Gastroenterol. Hepatol. 2017;14:573–584. doi: 10.1038/nrgastro.2017.88. PubMed DOI PMC

Knox N.C., Forbes J.D., Van Domselaar G., Bernstein C.N. The Gut Microbiome as a Target for IBD Treatment: Are We There Yet? Curr. Treat Opt. Gastroenterol. 2019;17:115–126. doi: 10.1007/s11938-019-00221-w. PubMed DOI

Buttó L.F., Haller D. Dysbiosis in intestinal inflammation: Cause or consequence. Int. J. Med. Microbiol. 2016;306:302–309. doi: 10.1016/j.ijmm.2016.02.010. PubMed DOI

Gong D., Gong X., Wang L., Yu X., Dong Q. Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol. Res. Pract. 2016;2016:6951091. doi: 10.1155/2016/6951091. PubMed DOI PMC

Zakerska-Banaszak O., Tomczak H., Gabryel M., Baturo A., Wolko L., Michalak M., Malinska N., Mankowska-Wierzbicka D., Eder P., Dobrowolska A., et al. Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: A pilot study. Sci. Rep. 2021;11:2166. doi: 10.1038/s41598-021-81628-3. PubMed DOI PMC

Sheehan D., Moran C., Shanahan F. The microbiota in inflammatory bowel disease. J. Gastroenterol. 2015;50:495–507. doi: 10.1007/s00535-015-1064-1. PubMed DOI

Sha S., Xu B., Wang X., Zhang Y., Wang H., Kong X., Zhu H., Wu K. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. Diagn. Microbiol. Infect. Dis. 2013;75:245–251. doi: 10.1016/j.diagmicrobio.2012.11.022. PubMed DOI

Papa E., Docktor M., Smillie C., Weber S., Preheim S.P., Gevers D., Giannoukos G., Ciulla D., Tabbaa D., Ingram J., et al. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS ONE. 2012;7:e39242. doi: 10.1371/journal.pone.0039242. PubMed DOI PMC

Ling Z., Jin C., Xie T., Cheng Y., Li L., Wu N. Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population. Sci. Rep. 2016;6:30673. doi: 10.1038/srep30673. PubMed DOI PMC

Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 2005;102:11070–11075. doi: 10.1073/pnas.0504978102. PubMed DOI PMC

Schierová D., Březina J., Mrázek J., Fliegerová K.O., Kvasnová S., Bajer L., Drastich P. Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy. Cells. 2020;9:2283. doi: 10.3390/cells9102283. PubMed DOI PMC

Noor S.O., Ridgway K., Scovell L., Kemsley E.K., Lund E.K., Jamieson C., Johnson I.T., Narbad A. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010;10:134. doi: 10.1186/1471-230X-10-134. PubMed DOI PMC

Conte M.P., Schippa S., Zamboni I., Penta M., Chiarini F., Seganti L., Osborn J., Falconieri P., Borrelli O., Cucchiara S. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut. 2006;55:1760–1767. doi: 10.1136/gut.2005.078824. PubMed DOI PMC

Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci USA. 2010;107:12204–12209. doi: 10.1073/pnas.0909122107. PubMed DOI PMC

Hansen J.J., Huang Y., Peterson D.A., Goeser L., Fan T.J., Chang E.B., Sartor R.B. The colitis-associated transcriptional profile of commercial Bacteroides thetaiotaomicron enhances adaptive immune responses to a bacterial antigen. PLoS ONE. 2012;7:e42645. doi: 10.1371/journal.pone.0042645. PubMed DOI PMC

Bloom S.M., Bijanki V.N., Nava G.M., Sun L., Malvin N.P., Donermeyer D.L., Dunne W.M., Allen P.M., Stappenbeck T.S. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe. 2011;9:390–403. doi: 10.1016/j.chom.2011.04.009. PubMed DOI PMC

Shin N.R., Lee J.C., Lee H.Y., Kim M.S., Whon T.W., Lee M.S., Bae J.W. An increase in the Akkermansia spp. Population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014;63:727–735. doi: 10.1136/gutjnl-2012-303839. PubMed DOI

Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA. 2013;110:9066–9071. doi: 10.1073/pnas.1219451110. PubMed DOI PMC

Lepage P., Häsler R., Spehlmann M.E., Rehman A., Zvirbliene A., Begun A., Ott S., Kupcinskas L., Doré J., Raedler A., et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology. 2011;141:227–236. doi: 10.1053/j.gastro.2011.04.011. PubMed DOI

Vacca M., Celano G., Calabrese F.M., Portincasa P., Gobbetti M., De Angelis M. The Controversial Role of Human Gut Lachnospiraceae. Microorganisms. 2020;8:573. doi: 10.3390/microorganisms8040573. PubMed DOI PMC

Schwiertz A., Jacobi M., Frick J.S., Richter M., Rusch K., Köhler H. Microbiota in pediatric inflammatory bowel disease. J. Pediatr. 2010;157:240–244, e241. doi: 10.1016/j.jpeds.2010.02.046. PubMed DOI

Nagao-Kitamoto H., Shreiner A.B., Gillilland M.G., Kitamoto S., Ishii C., Hirayama A., Kuffa P., El-Zaatari M., Grasberger H., Seekatz A.M., et al. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice. Cell Mol. Gastroenterol. Hepatol. 2016;2:468–481. doi: 10.1016/j.jcmgh.2016.02.003. PubMed DOI PMC

Yang H., Mirsepasi-Lauridsen H.C., Struve C., Allaire J.M., Sivignon A., Vogl W., Bosman E.S., Ma C., Fotovati A., Reid G.S., et al. Ulcerative Colitis-associated. Gut Microbes. 2020;12:1847976. doi: 10.1080/19490976.2020.1847976. PubMed DOI PMC

Keighley M.R., Arabi Y., Dimock F., Burdon D.W., Allan R.N., Alexander-Williams J. Influence of inflammatory bowel disease on intestinal microflora. Gut. 1978;19:1099–1104. doi: 10.1136/gut.19.12.1099. PubMed DOI PMC

Gu S., Chen D., Zhang J.N., Lv X., Wang K., Duan L.P., Nie Y., Wu X.L. Bacterial community mapping of the mouse gastrointestinal tract. PLoS ONE. 2013;8:e74957. doi: 10.1371/journal.pone.0074957. PubMed DOI PMC

Donaldson G.P., Lee S.M., Mazmanian S.K. Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol. 2016;14:20–32. doi: 10.1038/nrmicro3552. PubMed DOI PMC

Tannock G.W. The bowel microbiota and inflammatory bowel diseases. Int. J. Inflam. 2010;2010:954051. doi: 10.4061/2010/954051. PubMed DOI PMC

Louis P., Flint H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 2009;294:1–8. doi: 10.1111/j.1574-6968.2009.01514.x. PubMed DOI

Song C.S., Park D.I., Yoon M.Y., Seok H.S., Park J.H., Kim H.J., Cho Y.K., Sohn C.I., Jeon W.K., Kim B.I. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig. Dis. Sci. 2012;57:1033–1038. doi: 10.1007/s10620-011-1978-2. PubMed DOI